Needham & Company reiterates a 'Buy' on Flextronics (FLEX); F4Q Reported With Disappointing Guidance. However, Valuation Remains Compelling
Tweet
Share
E-mailGet Alerts FLEX Hot Sheet
Price: $110.32 --0%
Rating Summary:
18 Buy, 8 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
18 Buy, 8 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Needham & Company reiterates a 'Buy' on Flextronics (NASDAQ: FLEX), PT lowered from $10 to $9.
Needham analyst says, "Flextronics demonstrated that its increasingly diversified model is clearly not immune to hiccups in demand. Despite early C11 challenges in Infrastructure and Computing (now largely believed to be behind), we believe the company’s scale and position across end-markets should allow the company to post respectable overall growth as the EMS space remains healthy...For F1Q, our estimates become $7.35B and $0.22, vs. our previous forecast of $7.5B and $0.24 (ex. opt.). Our F12 estimates now $31.2 and $0.98 vs. prior $31.8B and $1.04."
For more ratings news on Flextronics click here and for the rating history of Flextronics click here.
Shares of Flextronics closed at $7.51 yesterday.
Needham analyst says, "Flextronics demonstrated that its increasingly diversified model is clearly not immune to hiccups in demand. Despite early C11 challenges in Infrastructure and Computing (now largely believed to be behind), we believe the company’s scale and position across end-markets should allow the company to post respectable overall growth as the EMS space remains healthy...For F1Q, our estimates become $7.35B and $0.22, vs. our previous forecast of $7.5B and $0.24 (ex. opt.). Our F12 estimates now $31.2 and $0.98 vs. prior $31.8B and $1.04."
For more ratings news on Flextronics click here and for the rating history of Flextronics click here.
Shares of Flextronics closed at $7.51 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Needham Starts Faeth Therapeutics (FTH) at Buy
- Abbott Labs (ABT) PT Raised to $135 at TD Cowen
- Idex Corp. (IEX) Reiterated at Buy by Stifel
Create E-mail Alert Related Categories
Analyst CommentsRelated Entities
Needham & CompanySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
